Advanced Enzymes: Smaller Businesses Outpace Human Nutrition
Key highlights
- Industrial Bio-Processing revenue increased 43% year on year to Rs 36.5 crore in Q2 FY27, the fastest growth among Advanced Enzymes’ segments.
- Animal Nutrition revenue grew 37% year on year to Rs 26.5 crore in Q2 FY27, while Specialized Manufacturing rose 25% to Rs 23.1 crore.
- Human Nutrition remained the largest business at 60% of Q2 FY27 sales, but revenue grew 6% to Rs 128.5 crore.
- Advanced Enzymes’ consolidated Q2 FY27 revenue rose 16% to Rs 214.5 crore, while EBITDA increased 20% to Rs 72.1 crore.
powered by IRIS

Advanced Enzymes reported faster Q2 FY27 growth in Industrial Bio-Processing and Specialized Manufacturing than in Human Nutrition, its largest business. Industrial Bio-Processing revenue rose 43% year on year to Rs 36.5 crore and Specialized Manufacturing rose 25% to Rs 23.1 crore, while Human Nutrition grew 6% to Rs 128.5 crore.
Know Advanced Enzyme Technologies inside out
Results, valuation, peers and who's buying, in one view.
Which Advanced Enzymes segments grew fastest in Q2 FY27?
Industrial Bio-Processing was Advanced Enzymes’ fastest-growing reported segment in Q2 FY27, increasing 43% year on year from Rs 25.5 crore to Rs 36.5 crore. The segment accounted for 17% of revenue from operations in the quarter, compared with Human Nutrition’s 60%, Animal Nutrition’s 12% and Specialized Manufacturing’s 11%.
Specialized Manufacturing ranked second by quarterly growth, with sales rising 25% from Rs 18.5 crore in Q2 FY26 to Rs 23.1 crore in Q2 FY27. Animal Nutrition grew 37% to Rs 26.5 crore from Rs 19.3 crore, also outpacing the 6% increase in the substantially larger Human Nutrition segment.
The quarterly ranking shows that the three businesses outside Human Nutrition collectively represented 40% of sales, based on the presentation’s stated segment shares. Human Nutrition did not decline in rupee terms: its revenue increased by Rs 7.3 crore year on year, but the smaller businesses added revenue at higher percentage rates in Q2 FY27.
How did Advanced Enzymes’ revenue mix change in the first half?
Advanced Enzymes’ first-half figures show Industrial Bio-Processing and Specialized Manufacturing gaining reported sales share while Human Nutrition was broadly unchanged. Industrial Bio-Processing represented 17% of H1 FY27 revenue, compared with 13% in H1 FY26, after revenue increased 37% from Rs 49.1 crore to Rs 67.1 crore.
Specialized Manufacturing accounted for 11% of H1 FY27 sales, compared with 9% a year earlier, as revenue rose 32% from Rs 32.7 crore to Rs 43.1 crore. Animal Nutrition increased 14% to Rs 51.7 crore and represented 13% of first-half sales, while Human Nutrition represented about 60% of sales in both periods.
Human Nutrition’s half-year revenue rose by Rs 0.9 crore, which the presentation describes as flat, despite the 6% rise recorded in Q2. The contrast between the quarter and the half year follows Q1 FY27 Human Nutrition revenue of Rs 115.8 crore, below the Rs 128.5 crore reported for Q2 FY27.
Got a follow-up? Ask IRIS
What drove Industrial Bio-Processing growth at Advanced Enzymes?
Food applications drove most of Advanced Enzymes’ Industrial Bio-Processing revenue and its Q2 FY27 expansion. Food business revenue was Rs 30.5 crore, equal to 14% of overall quarterly revenue, and grew 48% year on year and 16% sequentially, according to the presentation.
Non-Food Industrial Bio-Processing revenue was Rs 6 crore in Q2 FY27, equal to 3% of overall sales. It grew 21% year on year and 37% sequentially, contributing to the segment’s overall 19% quarter-on-quarter increase from Rs 30.6 crore in Q1 FY27 to Rs 36.5 crore in Q2 FY27.
The first-half composition was less uniform than the quarterly trend. Food revenue reached Rs 56.8 crore in H1 FY27 and grew 49% year on year, while Non-Food revenue was Rs 10.3 crore and declined 7% year on year. The segment’s 37% first-half growth was therefore led by food rather than by both sub-businesses moving in the same direction.
Did Specialized Manufacturing sustain its growth momentum?
Specialized Manufacturing sustained growth across both the Q2 and H1 comparisons disclosed by Advanced Enzymes. Quarterly sales rose 15% sequentially from Rs 20 crore in Q1 FY27 to Rs 23.1 crore in Q2 FY27, following the 25% year-on-year increase from Rs 18.5 crore.
The segment’s H1 FY27 revenue of Rs 43.1 crore was Rs 10.4 crore above the Rs 32.7 crore recorded in H1 FY26. Its 32% first-half growth exceeded the company’s 10% increase in consolidated revenue from operations, which reached Rs 406.2 crore in H1 FY27.
The quarterly series shows Specialized Manufacturing at Rs 12 crore in Q2 FY25, Rs 15.4 crore in both Q3 and Q4 FY25, Rs 18.5 crore in Q2 FY26, and Rs 23.1 crore in Q2 FY27. That sequence documents a higher Q2 FY27 sales level than the comparable quarter in each of the preceding two financial years presented.
How did the faster-growing segments coincide with consolidated results?
Advanced Enzymes reported consolidated Q2 FY27 revenue of Rs 214.5 crore, up 16% year on year from Rs 184.5 crore. Earnings before interest, tax, depreciation and amortisation, or EBITDA, increased 20% to Rs 72.1 crore, while profit after tax, or PAT before minority, increased 14% to Rs 51.2 crore.
The company reported a Q2 FY27 EBITDA margin of 34% and PAT margin of 24%. On a sequential basis, consolidated revenue grew 12% from Rs 191.7 crore in Q1 FY27, EBITDA rose 36% from Rs 52.9 crore, and PAT rose 33% from Rs 38.6 crore.
First-half growth was lower than the Q2 rate: revenue increased 10% to Rs 406.2 crore, EBITDA rose 7% to Rs 125 crore, and PAT rose 5% to Rs 89.7 crore. India was the largest geographic market at Rs 111 crore in Q2 FY27, up 25% year on year, while the Americas rose 4% to Rs 57.9 crore.
Conclusion
Advanced Enzymes’ Q2 FY27 figures show a business mix in which Human Nutrition remained the largest contributor at 60% of sales, but Industrial Bio-Processing, Animal Nutrition and Specialized Manufacturing grew more quickly. The first-half data reinforces the pattern: Industrial Bio-Processing’s share rose from 13% to 17%, and Specialized Manufacturing’s rose from 9% to 11%.
The next reported periods will show whether this mix movement persists, particularly because Human Nutrition grew only 0.4% in H1 FY27 and Industrial Bio-Processing Non-Food revenue declined 7% in the first half. The presentation also shows food applications growing 49% in Industrial Bio-Processing, making that sub-business a disclosed component to track against the Rs 67.1 crore first-half segment total.


